Is the management of hepatitis C patients appropriate? A population-based study

Aliment Pharmacol Ther. 2005 Apr 15;21(8):1007-15. doi: 10.1111/j.1365-2036.2005.02393.x.

Abstract

Background: In order for hepatitis C patients to receive antiviral treatment, they must reach medical care.

Aim: To assess the proportion of patients reaching medical care after hepatitis C diagnosis in a general population (1 006 171 inhabitants) in France.

Methods: Between 1994 and 1999, 1508 cases were diagnosed, of which 1251 were eligible for the study.

Results: Two-hundred and two patients did not have any medical care; among them, 55.4% had normal alanine transferase, 58.4% had risk factors related to lifestyle and 22.8% were alcoholics. Amongst the 1049 other patients, 41.6% had a liver biopsy, 25.0% were treated. Treatment was more often carried out in males than in females (OR: 1.59; P = 0.001), and in patients under 65 than in older patients (OR: 2.22; P < 0.008). Among non-treatment reasons, alcoholism (P = 0.001), drug-addiction (P = 0.04) and escaping monitoring (P = 0.04) were more frequent in males than in females, whereas normal alanine transferase was more frequent in females than in males (P = 0.004). Amongst 278 patients with a Metavir score >A1F1, 71 (25.5%) did not undergo treatment.

Conclusion: In a general population, one patient in six did not receive on-going health care; a quarter of patients with a Metavir score >A1F1 did not receive any treatment. These results showed insufficient clinical management, which could compromise the effectiveness of treatment in general population.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Antiviral Agents / therapeutic use*
  • Delivery of Health Care / standards
  • Early Diagnosis
  • Female
  • France / epidemiology
  • Hepatitis C, Chronic / diagnosis
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Risk Factors
  • Rural Health
  • Severity of Illness Index
  • Time Factors
  • Urban Health

Substances

  • Antiviral Agents